Status:
TERMINATED
Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
Lead Sponsor:
Conor Medsystems
Collaborating Sponsors:
Getz Pharma
Conditions:
Coronary Disease
Eligibility:
All Genders
20-95 years
Phase:
NA
Brief Summary
This trial aims to demonstrate the non-inferiority of the CI-CMS-005 Coronary Stent System to the study device as well as to the TAXUS™ Express2™ Drug-Eluting Coronary Stent System in in-segment late ...
Detailed Description
This is a complementary, multi-center, open-label, single-arm trial investigating angiographic and clinical patient outcomes in Japan. Historical data from the 2-arm randomized COSTAR II trial will be...
Eligibility Criteria
Inclusion
- General Inclusion Criteria
- Eligible for percutaneous coronary intervention (PCI)
- Documented stable or unstable angina pectoris (Class I, II, III or IV), documented ischemia, or documented silent ischemia
- Documented LVEF ≥25% within the last 6 weeks.
- Eligible for coronary artery bypass graft surgery (CABG)
Exclusion
- General
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00415961
Start Date
November 1 2006
End Date
May 1 2012
Last Update
January 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shonan Kamakura General Hospital
Kamakura, Japan, 247-8533